Bicycle Therapeutics (BCYC) Other Operating Expenses (2018 - 2026)
Bicycle Therapeutics' (BCYC) quarterly Other Operating Expenses came in at -$2.0 million in Q2 2026, up 15.21% YoY from -$1.7 million in Q2 2025, and up 22.23% on a QoQ basis from -$2.5 million in Q1 2026.
Bicycle Therapeutics (BCYC) Other Operating Expenses (2018 - 2026) Analysis & Trends
Bicycle Therapeutics (BCYC) has 5 years of Other Operating Expenses data on file, last reported at -$2.0 million in Q2 2026.
- Quarterly Other Operating Expenses rose 15.21% year-over-year to -$2.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$9.6 million (up 0.71% YoY) and the FY2025 annual result came in at -$9.6 million, down 5.86% from the prior year.
- Other Operating Expenses climbed to -$2.0 million in Q2 2026, from -$2.5 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of -$1.9 million in Q2 2024 to a low of -$2.6 million in Q4 2024.
- A 3-year average of -$2.3 million and a median of -$2.4 million in 2025 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2025 — Other Operating Expenses slipped 21.45% — and 2026, when it climbed 15.21%.
- Tracing BCYC's Other Operating Expenses over 3 years: stood at -$2.6 million in 2024, then changed by 0.0% to -$2.6 million in 2025, then advanced by 23.65% to -$2.0 million in 2026.
- The last three Other Operating Expenses figures came in at -$2.0 million (Q2 2026), -$2.5 million (Q1 2026), and -$2.6 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Bicycle Therapeutics | 272.28 Mn | 272.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.97 Mn |
| Mar 31, 2026 | -2.54 Mn |
| Dec 31, 2025 | -2.58 Mn |
| Sep 30, 2025 | -2.47 Mn |
| Jun 30, 2025 | -2.33 Mn |
| Mar 31, 2025 | -2.19 Mn |
| Dec 31, 2024 | -2.58 Mn |
| Sep 30, 2024 | -2.53 Mn |
| Jun 30, 2024 | -1.92 Mn |
| Mar 31, 2024 | -2.02 Mn |
| Dec 31, 2020 | -1,000.00 |
| Mar 31, 2018 | 5.70 Mn |